Enteric Dissolution Enhancement of Engineered Gastro Resistant Omeprazole Tablets using Hydroxypropyl Methylcellulose Acetate Succinate

被引:2
作者
Mohapatra, Sagar Kumar [1 ]
Sahoo, Rudra Narayan [1 ,2 ]
Mallick, Subrata [1 ]
Mohapatra, Rajaram [1 ]
机构
[1] Siksha O Anusandhan Deemed Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Bhubaneswar 751003, Odisha, India
[2] Centurion Univ Technol & Management, Sch Pharm & Life Sci, Bhubaneswar, Odisha, India
关键词
Proton pump inhibitor; Enteric coating; HPMC; Omeprazole; Dissolution enhancement; IN-VITRO; RELEASE; FORMULATION; MECHANISM; HPMCAS;
D O I
10.5530/ijper.55.3.139
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Purpose: Oral drug delivery system has always been a preferred choice for the treatment of peptic ulcer and gastroesophageal reflux diseases. Being a proton pump inhibitor omeprazole restricts gastric acid secretion but the foremost downside is its degradation in acidic environments. The systemic absorption of gastro-unstable drugs can be improved by the enteric coating. Materials and Methods: This study was aimed at developing an effective enteric coating for omeprazole tablets using HPMC E5-LV and Hydroxypropyl Methylcellulose Acetate Succinate (HPMC-AS) polymers. The core tablets were subcoated with HPMC E5-LV which acted as a barrier between core tablet and enteric coated tablet. The enteric coating was applied using HPMC-AS. Results: Dissolution information unveiled that the enteric coat remained in place for 2 hr in acidic medium (0.1N HCl) and later dissolved when came in contact with basic media (acetate buffer pH 6.8), it dissolved within a jiffy. Conclusion: The release profile showed 91 to 98% drug release within 1hr in pH 6.8 Acetate buffer. Further instrumental analysis was performed to ascertain drug-polymer interaction.
引用
收藏
页码:677 / 684
页数:8
相关论文
共 21 条
[1]   Infrared Spectroscopy for Analysis of Co-processed Ibuprofen and Magnesium Trisilicate at Milling and Freeze Drying [J].
Acharya, Manoj ;
Mishra, Satyaki ;
Sahoo, Rudra N. ;
Mallick, Subrata .
ACTA CHIMICA SLOVENICA, 2017, 64 (01) :45-54
[2]  
Badillo Raul, 2014, World J Gastrointest Pharmacol Ther, V5, P105, DOI 10.4292/wjgpt.v5.i3.105
[3]   Formulation and in vivo evaluation of omeprazole buccal adhesive tablet [J].
Choi, HG ;
Jung, JH ;
Yong, CS ;
Rhee, CD ;
Lee, MK ;
Han, JH ;
Park, KM ;
Kim, CK .
JOURNAL OF CONTROLLED RELEASE, 2000, 68 (03) :405-412
[4]   Formulation and Evaluation of Omeprazole Tablets for Duodenal Ulcer [J].
Choudhury, A. ;
Das, S. ;
Bahadur, S. ;
Saha, S. ;
Roy, A. .
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 72 (04) :491-U91
[5]   Gastro-resistant characteristics of GRAS-grade enteric coatings for pharmaceutical and nutraceutical products [J].
Czarnocka, Justyna K. ;
Alhnan, Mohamed A. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 486 (1-2) :167-174
[6]  
Dash S, 2010, ACTA POL PHARM, V67, P217
[7]   Developing a stable aqueous enteric coating formulation with hydroxypropyl methylcellulose acetate succinate (HPMCAS-MF) and colloidal silicon dioxide as anti-tacking agent [J].
Deshpande, Tanvi M. ;
Quadir, Anisul ;
Obara, Sakae ;
Ibrahim, Ahmed ;
Hoag, Stephen W. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 542 (1-2) :108-116
[8]   Comparative study of preparation and characterization of enteric and enhanced release omeprazole microparticles [J].
El-Badry, M. .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2011, 21 (06) :491-496
[9]   Dissolution of omeprazole from delayed-release solid oral dosage forms [J].
Farinha, A ;
Bica, A ;
Martins, JM ;
Pais, JP .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (07) :785-790
[10]   CLINICAL-PHARMACOLOGY OF OMEPRAZOLE [J].
HOWDEN, CW .
CLINICAL PHARMACOKINETICS, 1991, 20 (01) :38-49